Skip to content
naulon
Not checkedNot checked for notices yet.

Case report: ICI-induced hepatitis and myositis with aspergillosis

Cornelia Banciu-Odell, Olivia Castillo, Liang Yu and 3 more

Oncolog-Hematolog.ro · 2025

doi:10.26416/onhe.71.2.2025.10792 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

We report the case of a 41-year-old woman with metastatic melanoma who developed grade 4 immune checkpoint in­hi­bi­tor (ICI)-induced hepatitis and autoimmune myositis fol­lo­wing combination therapy with nivolumab and ipi­li­mu­mab. Liver biopsy confirmed the diagnosis, and her he­pa­ti­tis proved refractory to high-dose corticosteroids, re­qui­r­ing escalation to mycophenolate mofetil (MMF) and sub­sequently tacrolimus. She also developed bilateral lo­wer extremity weakness consistent with immune-re­la­ted myositis, and she was diagnosed with pulmonary as­per­gil­lo­sis during hospitalization. This case highlights the importance of early recognition, tissue diagnosis, mul­ti­dis­ci­pli­na­ry coordination, and proactive infection monitoring in the management of high-grade immune-related adverse events (irAEs).

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.